
Dr. Amy Paller discusses the clinical utility of TARC measurements in AD management at EADV 2025
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.

Tune in as Dr. Jason Hawkes describes how to assess disease activity in chronic spontaneous urticaria.
Use this educational tool to explore the daily burden of loss of smell for patients with CRSwNP.

Explore the dynamic advancements in COPD biologic therapies. Prof. Klaus Rabe, MD, Prof. Claus Vogelmeier, MD, and Prof. Wisia Wedzicha, MD, present and analyze the latest clinical data, offering key insights into current and emerging therapeutic strategies for managing COPD.
This infographic provides an overview of clinical remission in asthma, including its evolving definitions, key remission criteria, supporting evidence, and its importance as a treatment goal in asthma management.

This infographic illustrates the ongoing burden associated with maintenance oral corticosteroid (OCS) use and high-dose inhaled corticosteroids (ICS) in asthma, including the clinical impact of corticosteroid exposure, supporting evidence, and the importance of considering corticosteroid burden in asthma management.

This infographic explores the heterogeneity of chronic spontaneous urticaria (CSU) across patient subpopulations and highlights differences in demographic and clinical characteristics that may impact disease burden and management.

Join experts G. Walter Canonica, Vibeke Backer, and Joaquim Mullol for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang reviews the key considerations for management of AD that is uncontrolled with topical therapies in children and the criteria to determine whether a patient is indicated for systemic therapy